Status:
COMPLETED
Analysis of Trends Over Time of Hepatitis Related Incidence in Panama
Lead Sponsor:
GlaxoSmithKline
Conditions:
Hepatitis
Eligibility:
All Genders
Brief Summary
The purpose of this study is to analyze the incidence of baseline hepatitis related outcomes (viral hepatitis A and unspecified viral hepatitis) together with the current frequency of the same outcome...
Detailed Description
In this study, systematic review of the databases of epidemiologic surveillance system (Ministry of Health), for hepatitis related outcomes will be performed. The analysis will be performed by age gro...
Eligibility Criteria
Inclusion
- Hepatitis related outcomes occurred during the period analyzed and registered in the Epidemiologic Surveillance System of the Ministry of Health, will be collected for the study
Exclusion
- Not applicable
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01159951
Start Date
January 1 2009
End Date
August 1 2011
Last Update
June 7 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Clayton, Provincia de Panamá, Panama